No description available.

No description available.

Photocopy of typescript. / Digitized by Kansas Correctional Industries

Dialyzable leucocytic extracts (Transfer Factor) were prepared from guinea pigs, rabbits, dogs and cattle sensitized to tuberculin, from cattle and dogs reactive to coccidioidin and from cattle sensitized to 2,4 dinitrochlorobenzene and Pasteurella multocida. These Transfer Factor (TF) preparations were used in intra- and interspecies transfers of delayed hypersensitivity (DH) and cellular immunity (CMI) in guinea pigs, rabbits, dogs, cattle and humans. Various doses and routes of administration were employed. Success of transfer was based upon dermal skin reactivity and/or clinical improvement. Our results suggest the following: (a) interspecies transfer of DH is effective with a variety of species, (b) oral administration of TF is effective and (c) cattle are effective donors of TF for use in humans and other animals because of potential quantity and strong potency of transfer material.

No description available.

No description available.

Typescript / Includes bibliographical references. (p. [1]-[20]) / 171, [20] leaves : ill. ; 26 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Thesis (Ph.D.)--University of Adelaide, Dept. of Zoology, 1966

No description available.

No description available.

Cyclophosphamide (CY) was injected intraperitoneally into mice at varying dosage levels 48 hours prior to intravenous inoculation of constant amounts of dialysable leucocytic transfer factor (TF). Bovine TF to coccidioidin and Brucella abortus and porcine TF to Mycobacterium avium were used. Twenty-four hours after TF injections, mice were tested for delayed hypersensitivity by footpad inoculation with specific antigens. The results show that CY slightly enhanced the delayed hypersensitivity response to the specific test antigens in all three systems. This was not true at every CY dose level, however, since there was a correlation between the dosage of CY and the time of peak footpad swelling. Cyclophosphamide at a low level (20 mg/kg body wt) caused the maximal reading at 24 hours after test, whereas the high level dose (200 mg/kg) showed greatest thickening of the footpad at 48 hours. Transfer factor dosage differences appeared to change the response relatively little, if at all. The cyclophosphamide dose response, on the other hand, showed disparities among various antigen systems and at the different observation times. Under these conditions, no consistent, striking effects of CY on transfer could be noted.